XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Interim Statements of Cash Flows (unaudited) - CAD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Jun. 30, 2021
Cash flows from (used in) operating activities          
Net loss $ (8,567,905) $ (5,764,090) $ (17,926,893) $ (8,551,597)  
Add items not affecting cash          
Share-based payment     1,186,845 291,221  
Interest accrued     48,033  
Foreign exchange     (30,257) (417,710)  
Amortisation – pilot plant     7,342,858 4,724,990  
Amortisation – intangible asset     96,303 96,302  
Amortisation – office lease 20,736 20,736  
Interest expense     4,215  
Net changes in non-cash working capital items to operations:          
Receivables     (7,288) (89,480)  
Prepaid expenses     (2,243,512) (78,228)  
Accounts payable and accrued liabilities     (1,609,101) (1,446,204)  
Net cash used in operating activities     (13,166,094) (5,422,673)  
Cash flows used in investing activities          
Exploration and evaluation assets     (1,554,435) (1,094,953)  
Pilot plant     (800,859) (1,814,531)  
Commercial plant development     (166,565)  
Net cash used in investing activities     (2,521,859) (2,909,484)  
Cash flows from financing activities          
Proceeds from private placement, net of costs     120,452,352 31,871,382  
Share issuance costs     (241,396)  
Exercise of warrants     6,306,982 6,286,340 $ 10,190,569
Exercise of options     745,500 408,750 1,241,500
Lease payments     (22,856)  
Net cash from financing activities     127,240,582 38,566,472  
Net change in cash     111,552,629 30,234,315  
Cash, beginning of period     27,988,471 4,141,494 4,141,494
Cash, end of period $ 139,541,100 $ 34,375,809 $ 139,541,100 $ 34,375,809 $ 27,988,471